Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

PHARMAC AstraZeneca agree to continued drug supply

Media Release

PHARMAC, AstraZeneca agree to continued drug supply

People will be able to continue taking all dosage strengths of the calcium channel blocker drug felodipine.

PHARMAC Chief Executive Wayne McNee says an agreement reached between the Government drug funding agency and pharmaceutical company AstraZeneca will enable people to have uninterrupted access to the drug.

Wayne McNee says he is pleased that discussions with AstraZeneca have resulted in an agreement being reached.

[ends]

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.